IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Q3 2020 Holdings

Filed 2020-11-03 | 16 holdings | $145.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals(ARWR)COM04280A100$140.4M3,260,86996.7%
Aldeyra Therapeutics, Inc.(ALDX)COM01438T106$4.4M594,8343.0%
Fate Therapeutics, Inc.(FATE)COM31189P102$135.1K3,379,0640.1%
Legend Biotech Corporation(LEGN)SPONSORED ADS52490G102$50.3K1,629,1730.0%
Protagonist Therapeutics Inc.(PTGX)COM74366E102$47.9K2,449,1830.0%
Fusion Pharmaceuticals Inc.COM36118A100$44.1K3,670,5160.0%
MeiraGTx Holdings plc(MGTX)COMG59665102$38.4K2,898,5500.0%
BiomX Inc.COM09090D103$13.5K2,133,4020.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$7.9K662,6760.0%
Provention Bio, Inc.(PRVBUSD)COM74374N102$7.4K574,9730.0%
PhaseBio Pharmaceuticals, Inc.COM717224109$5.6K1,607,0440.0%
Castlight Health Inc.(CSLT1EUR)CL B14862Q100$917811,2950.0%
Tracon Pharmaceuticals, Inc.COM89237H209$43484,0030.0%
Catalyst Biosciences, Inc.COM14888D208$28866,9510.0%
Senseonics Holdings, Inc.(SENS1GBP)COM81727U105$204525,6320.0%
Genocea Biosciences, Inc.(GNCAQ)COM372427401$9943,1770.0%